These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 16094121)

  • 41. Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India.
    Mehrotra PK; Mishra A; Mishra SK; Agarwal G; Agarwal A; Verma AK
    World J Surg; 2011 Jun; 35(6):1273-80. PubMed ID: 21479684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follicular thyroid carcinoma in an iodine-replete endemic goiter region: a prospectively collected, retrospectively analyzed clinical trial.
    Asari R; Koperek O; Scheuba C; Riss P; Kaserer K; Hoffmann M; Niederle B
    Ann Surg; 2009 Jun; 249(6):1023-31. PubMed ID: 19474675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymph node involvement in macroscopic medullary thyroid carcinoma.
    Tamagnini P; Iacobone M; Sebag F; Marcy M; De Micco C; Henry JF
    Br J Surg; 2005 Apr; 92(4):449-53. PubMed ID: 15672437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Familial non-medullary thyroid cancer: a matched-case control study.
    Maxwell EL; Hall FT; Freeman JL
    Laryngoscope; 2004 Dec; 114(12):2182-6. PubMed ID: 15564841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables.
    Dottorini ME; Assi A; Sironi M; Sangalli G; Spreafico G; Colombo L
    Cancer; 1996 Apr; 77(8):1556-65. PubMed ID: 8608543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in risk factors and Tumor Node Metastasis stage of sporadic medullary thyroid carcinoma over 41 years, before and after the routine measurements of serum calcitonin.
    Karga H; Giagourta I; Papaioannou G; Doumouchtsis K; Polymeris A; Thanou S; Papamichael K; Zerva C
    Metabolism; 2011 May; 60(5):604-8. PubMed ID: 20667564
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines?
    Panigrahi B; Roman SA; Sosa JA
    Ann Surg Oncol; 2010 Jun; 17(6):1490-8. PubMed ID: 20224861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy.
    Samaan NA; Schultz PN; Hickey RC
    Horm Metab Res Suppl; 1989; 21():21-5. PubMed ID: 2807151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Decision making in postoperative incidentally found small C-cell-carcinoma].
    Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT
    Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.
    Wenig BM; Thompson LD; Adair CF; Shmookler B; Heffess CS
    Cancer; 1998 Feb; 82(4):740-53. PubMed ID: 9477108
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of lymph node yield and metastatic lymph node ratio in medullary thyroid carcinoma.
    Leggett MD; Chen SL; Schneider PD; Martinez SR
    Ann Surg Oncol; 2008 Sep; 15(9):2493-9. PubMed ID: 18594930
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma.
    Hay ID; Ryan JJ; Grant CS; Bergstralh EJ; van Heerden JA; Goellner JR
    Surgery; 1990 Dec; 108(6):972-9; discussion 979-80. PubMed ID: 2247843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
    Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
    Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma.
    Barbet J; Campion L; Kraeber-Bodéré F; Chatal JF;
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6077-84. PubMed ID: 16091497
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Surgical procedure in children with medullary thyroid gland carcinoma with reference to multiple endocrine neoplasia type II].
    Schäfer K; Senninger N; Roth H; Buhr HJ
    Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():202-4. PubMed ID: 9101831
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differentiated and medullary thyroid cancer in childhood and adolescence.
    La Quaglia MP; Telander RL
    Semin Pediatr Surg; 1997 Feb; 6(1):42-9. PubMed ID: 9117274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medullary thyroid carcinoma: a 20-year experience from a centre in South India.
    Finny P; Jacob JJ; Thomas N; Philip J; Rajarathnam S; Oommen R; Nair A; Seshadri MS
    ANZ J Surg; 2007 Mar; 77(3):130-4. PubMed ID: 17305985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Multiple endocrine type 2 neoplasia in 3 families].
    Palchik M; Sánchez A; Góméz J; Rodríguez Pécora A
    Medicina (B Aires); 1990; 50(2):117-23. PubMed ID: 1983220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome.
    Haq M; Harmer C
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):87-93. PubMed ID: 15963067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.